Mechanism of kindlin-3-dependent integrin activation
kindlin-3依赖性整合素激活机制
基本信息
- 批准号:10229369
- 负责人:
- 金额:$ 54.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-05 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Description
This is project 2 of the PPG “Cellular Mechanisms of Inflammation, Hemostasis, and Thrombosis”. Kindlin-3 is
known to be required for integrin activation in platelets and leukocytes. This is starkly illustrated by the human
disease Leukocyte Adhesion Deficiency-III. Patients with this disease have mutations in FERMT3, the gene
encoding kindlin-3, and suffer from life-threatening bleeding and bacterial infections. Infections result because
kindlin-3-deficient leukocytes including neutrophils cannot adhere to the vessel wall and thus fail to recruit to
sites of infection. Neutrophils express two β2 integrins, αLβ2 and αMβ2. We made and validated a humanized
mouse in which human β2 was knocked into the mouse β2 locus. In this mouse, β2 integrin activation can be
monitored by binding of mAbs 24 and KIM127, specific for activation epitopes in human β2. We propose to use
flow cytometry, live cell imaging by quantitative dynamic footprinting, superresolution microscopy by
SuperSTORM, recently developed in the Ley lab, and intravital microscopy in the β2 integrin humanized
mouse to address three specific aims: Specific Aim 1 is to test the role of the kindlin-3 PH domain in β2
integrin activation. We hypothesize that the PH domain is required for kindlin-3 recruitment to the plasma
membrane. We use retrovirally transduced neutrophilic cells expressing fluorescent fusion proteins of kindlin-3.
For in vivo assessment, we transduce kindlin-3-deficient hematopoitic stem cells with vectors encoding kindlin-
3 fusion proteins to achieve expression in primary mouse neutrophils in vivo. Specific Aim 2 is to test the
importance of kindlin-3 dimerization. Dimerization will be assessed by Förster Resonance Energy Transfer
(FRET), both in total internal reflection (TIRF) microscopy (near the membrane) and by confocal microscopy (in
the cytosol). We hypothesize that the PH domain also may contribute to dimerization, similar to the
dimerization of sharpin, which is studied in project 4. Specific Aim 3 is to test how kindlin-3 interacts with
talin-1 and β2 integrins. To test this, we make use of the existing mCherry FP-talin-1 transgenic mouse, since
talin-1 is too large for retroviral packaging. F(ab) made from the β2 integrin activation reporters KIM127 and
mAb24 will be used to assess β2 integrin conformations in vitro and, using the human β2 integrin knockin
mouse, in primary neutrophils in vivo. Project 2 will closely collaborate with project 1 by conducting live cell
and superresolution imaging to address the role of Rap-1 binding for talin-1 function. Project 1 investigators
will assist project 2 with various biochemical assays. When the proposed work is completed, we will
understand how kindlin-3 and talin-1 cooperate to enable β2 integrin-dependent neutrophil arrest under flow.
描述
这是PPG“炎症,止血和血栓形成的细胞机制”的项目2。 Kindlin-3是
已知是血小板和白细胞中整联蛋白激活所必需的。这是人类明确说明的
疾病白细胞粘附缺乏-III。该疾病的患者在FERMT3中有突变,该基因
编码Kindlin-3,并患有威胁生命的出血和细菌感染。导致感染是因为
Kindlin-3缺乏白细胞在内
感染部位。中性粒细胞表达两个β2整合素αLβ2和αMβ2。我们制作并验证了人源
将人β2敲入小鼠β2基因座的小鼠。在这只小鼠中,β2整合素激活可以是
通过MAB 24和KIM127的结合监测,特定于人β2的激活表位。我们建议使用
流式细胞仪,通过定量动态足迹,超分辨率显微镜的活细胞成像。
超级风暴,最近在Ley实验室中开发,β2整合素中的浸润式显微镜人性化的显微镜
小鼠要解决三个特定目的:特定目标1是测试β2中Kindlin-3 pH结构域的作用
整合素激活。我们假设pH结构域是Kindlin-3募集到等离子体所必需的
膜。我们使用表达Kindlin-3的荧光融合蛋白的逆转录病毒翻译的中性粒细胞。
为了进行体内评估,我们用编码Kindlin-
3融合蛋白在体内实现原代小鼠中性粒细胞的表达。特定目标2是测试
Kindlin-3二聚体的重要性。二聚化将通过Förster共振能量转移评估
(FRET),既有总内反射(TIRF)显微镜(膜附近)和共聚焦显微镜(在
细胞质)。我们假设pH结构域也可能有助于二聚化,类似于
Sharpin的二聚化,在项目4中进行了研究。具体目的3是测试Kindlin-3如何与
talin-1和β2整合素。为了进行测试,我们利用现有的MCHERRY FP-TALIN-1转基因鼠标,因为
Talin-1对于逆转录病毒包装太大。 F(AB)由β2整合素激活报告基因KIM127和
MAB24将用于评估体外β2整合素构象,并使用人β2整合素敲击素
小鼠,在体内原发性嗜中性粒细胞中。项目2将通过执行活细胞与项目1密切合作
和上分辨率成像,以解决RAP-1结合对TALIN-1功能的作用。项目1调查人员
将协助项目2进行各种生化测定。提出的工作完成后,我们将
了解Kindlin-3和Talin-1如何配合以使β2整合素依赖性嗜中性粒细胞在流动下抑制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Klaus F. Ley其他文献
Binding of function‐blocking mAbs to mouse and human P‐selectin glycoprotein ligand‐1 peptides with and without tyrosine sulfation
功能阻断单克隆抗体与小鼠和人 P-选择素糖蛋白配体 1 肽(有或没有酪氨酸硫酸化)的结合
- DOI:
- 发表时间:20022002
- 期刊:
- 影响因子:5.5
- 作者:Aravinda Thatte;S. Ficarro;K. Snapp;M. Wild;D. Vestweber;D. Hunt;Klaus F. LeyAravinda Thatte;S. Ficarro;K. Snapp;M. Wild;D. Vestweber;D. Hunt;Klaus F. Ley
- 通讯作者:Klaus F. LeyKlaus F. Ley
Serum levels of soluble intercellular adhesion molecule-1 (sICAM-1) correlate with severity of ileitis in experimental Crohn's disease: A novel marker of small intestinal inflammation
- DOI:10.1016/s0016-5085(00)85325-110.1016/s0016-5085(00)85325-1
- 发表时间:2000-04-012000-04-01
- 期刊:
- 影响因子:
- 作者:Jesus Rivera-Nieves;R. Cartland Burns;Christopher A. Moskaluk;Theresa T. Pizarro;Klaus F. Ley;Fabio CominelliJesus Rivera-Nieves;R. Cartland Burns;Christopher A. Moskaluk;Theresa T. Pizarro;Klaus F. Ley;Fabio Cominelli
- 通讯作者:Fabio CominelliFabio Cominelli
α<sub>4</sub>β<sub>1</sub>integrin (VLA-4) blockade reduces neointimal growth after carotid air desiccation injury in the ApoE (−/−) mouse
- DOI:10.1016/s0735-1097(02)80085-710.1016/s0735-1097(02)80085-7
- 发表时间:2002-03-062002-03-06
- 期刊:
- 影响因子:
- 作者:Kurt G. Barringhaus;J.William Phillips;John M. Sanders;Ann C. Czamik;Klaus F. Ley;Ian J. SarembockKurt G. Barringhaus;J.William Phillips;John M. Sanders;Ann C. Czamik;Klaus F. Ley;Ian J. Sarembock
- 通讯作者:Ian J. SarembockIan J. Sarembock
共 3 条
- 1
Klaus F. Ley的其他基金
Mechanism of kindlin-3-dependent integrin activation
kindlin-3依赖性整合素激活机制
- 批准号:1067689710676897
- 财政年份:2020
- 资助金额:$ 54.93万$ 54.93万
- 项目类别:
Vascular macrophages and T cells in atherosclerosis
动脉粥样硬化中的血管巨噬细胞和 T 细胞
- 批准号:1036971010369710
- 财政年份:2019
- 资助金额:$ 54.93万$ 54.93万
- 项目类别:
Vascular macrophages and T cells in atherosclerosis
动脉粥样硬化中的血管巨噬细胞和 T 细胞
- 批准号:1011295410112954
- 财政年份:2019
- 资助金额:$ 54.93万$ 54.93万
- 项目类别:
Vascular macrophages and T cells in atherosclerosis
动脉粥样硬化中的血管巨噬细胞和 T 细胞
- 批准号:98958589895858
- 财政年份:2019
- 资助金额:$ 54.93万$ 54.93万
- 项目类别:
Vascular macrophages and T cells in atherosclerosis
动脉粥样硬化中的血管巨噬细胞和 T 细胞
- 批准号:1062303410623034
- 财政年份:2019
- 资助金额:$ 54.93万$ 54.93万
- 项目类别:
Vascular macrophages and T cells in atherosclerosis
动脉粥样硬化中的血管巨噬细胞和 T 细胞
- 批准号:1056590710565907
- 财政年份:2019
- 资助金额:$ 54.93万$ 54.93万
- 项目类别:
Core E: Cell sorting, CyTOF and RNA-Seq
核心 E:细胞分选、CyTOF 和 RNA-Seq
- 批准号:1018860410188604
- 财政年份:2017
- 资助金额:$ 54.93万$ 54.93万
- 项目类别:
Core B: Single Cell Protein and RNA Sequencing Core
核心 B:单细胞蛋白质和 RNA 测序核心
- 批准号:1033409210334092
- 财政年份:2017
- 资助金额:$ 54.93万$ 54.93万
- 项目类别:
Super-resolution confocal microscope
超分辨率共焦显微镜
- 批准号:92748859274885
- 财政年份:2017
- 资助金额:$ 54.93万$ 54.93万
- 项目类别:
Project 4: APOB-specific CD4 and CD8 T cells exacerbate atherosclerosis
项目4:APOB特异性CD4和CD8 T细胞加剧动脉粥样硬化
- 批准号:1033409710334097
- 财政年份:2017
- 资助金额:$ 54.93万$ 54.93万
- 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Molecular basis of glycan recognition by T and B cells
T 和 B 细胞识别聚糖的分子基础
- 批准号:1054964810549648
- 财政年份:2023
- 资助金额:$ 54.93万$ 54.93万
- 项目类别:
Novel, Targeted Method for Bacteriophage Purification
噬菌体纯化的新型靶向方法
- 批准号:1069898310698983
- 财政年份:2023
- 资助金额:$ 54.93万$ 54.93万
- 项目类别:
Targeting cytochrome bd as an anti-biofilm strategy
靶向细胞色素 bd 作为抗生物膜策略
- 批准号:1064224310642243
- 财政年份:2023
- 资助金额:$ 54.93万$ 54.93万
- 项目类别:
Chemical tools to investigate chain-flipping in quorum signal synthases
研究群体信号合酶链翻转的化学工具
- 批准号:1064554810645548
- 财政年份:2023
- 资助金额:$ 54.93万$ 54.93万
- 项目类别: